emerging markets

Q&A: Zulf Masters on emerging markets

https://pharmaphorum.com/views-analysis-market-access/qa-zulf-masters-on-emerging-markets/

Takeda nets $660m from product selloff to Germany’s Stada

https://pharmaphorum.com/news/takeda-nets-660m-from-product-selloff-to-germanys-stada/

Navigating emerging markets – opportunities and challenges for pharma

https://pharmaphorum.com/views-analysis-market-access/navigating-emerging-markets-opportunities-and-challenges-for-pharma/

Global Pharmaceutical Regulatory Affairs Summit

https://pharmaphorum.com/events/global-pharmaceutical-regulatory-affairs-summit/

MINT: opportunities in ‘frontier’ markets?

https://pharmaphorum.com/articles/mint-opportunities-frontier-markets/

Six factors shaping healthcare in emerging markets

https://pharmaphorum.com/views-and-analysis/healthcare-emerging-markets/

Novo aims for GLP-1 sales growth in China

https://pharmaphorum.com/news/novo/

Pharma partners with African countries on chronic diseases

https://pharmaphorum.com/views-and-analysis/pharma-partners-african-countries-chronic-diseases/

Takeda preps for further acquisition

https://pharmaphorum.com/news/takeda-preps-acquisition/

1 2

Close in 10 seconds

Pharmaphorum.com

Search